Show simple item record

dc.contributor.authorKolinsky, M
dc.contributor.authorRescigno, P
dc.contributor.authorde Bono, JS
dc.date.accessioned2016-09-28T14:02:27Z
dc.date.issued2016-04
dc.identifier.citationJAMA oncology, 2016, 2 (4), pp. 437 - 438
dc.identifier.issn2374-2437
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/146
dc.identifier.eissn2374-2445
dc.identifier.doi10.1001/jamaoncol.2015.4918
dc.formatPrint
dc.format.extent437 - 438
dc.languageeng
dc.language.isoeng
dc.subjectHumans
dc.subjectProstatic Neoplasms
dc.subjectHydrocortisone
dc.subjectAndrogen Antagonists
dc.subjectCastration
dc.subjectOrchiectomy
dc.subjectGonadotropin-Releasing Hormone
dc.titleChemical or Surgical Castration--Is This Still an Important Question?
dc.typeJournal Article
rioxxterms.versionofrecord10.1001/jamaoncol.2015.4918
rioxxterms.licenseref.startdate2016-04
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfJAMA oncology
pubs.issue4
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.publication-statusPublished
pubs.volume2
pubs.embargo.termsNo embargo
icr.researchteamProstate Cancer Targeted Therapy Groupen_US
dc.contributor.icrauthorRescigno, Pasqualeen
dc.contributor.icrauthorDe Bono, Johannen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record